Low Dose Cohort Safely Dosed In Retinitis Pigmentosa Initial Clinical Trial
RetroSense Therapeutics LLC announced that the low dose cohort safely dosed in Retinitis Pigmentosa clinical trial. Now trial can proceed to mid dose cohort.
Read More
Clinical trials